According to GuruFocus Insider Data, the largest CFO buys during the past week GenMark Diagnostics Inc., Regeneration Technologies Inc., Oak Ridge Financial Services Inc., PokerTek Inc., CELLDEX THERAPEUTICS, INC, GNMK
GenMark Diagnostics Inc. (GNMK, Financial): CFO, Treasurer & Secretary Steven J Kemper Bought 5,000 Shares
CFO, Treasurer & Secretary of GenMark Diagnostics Inc. (GNMK) Steven J Kemper bought 5,000 shares on 09/08/2010 at an average price of $4.12. GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. Genmark Diagnostics Inc. has a market cap of $45.8 million; its shares were traded at around $3.91 .
GenMark Diagnostics, Inc. reported revenues of $651,000 for the quarter ending June 30, 2010, a 162% increase over second quarter 2009. Net loss for the second quarter was $5.1 million, or $0.60 per share, compared to a net loss of $4.3 million and $1.08 per share for the same period last year.
CFO, Treasurer & Secretary Steven J Kemper bought shares of GNMK stock.
Regeneration Technologies Inc. (RTIX, Financial): Executive Vice President/CFO Robert P Jordheim Bought 5,000 Shares
Executive Vice President/CFO of Regeneration Technologies Inc. (RTIX) Robert P Jordheim bought 5,000 shares on 09/09/2010 at an average price of $2.15. RTI BIOLOGICS, Inc. prepares human donated tissue and bovine tissue for transplantation with a commitment to advancing science, safety and innovation. Regeneration Technologies Inc. has a market cap of $123.2 million; its shares were traded at around $2.25 with a P/E ratio of 25 and P/S ratio of 0.7.
RTI International Metals, Inc. released results recently for the second quarter of 2010. During the second quarter, RTI reported net income of $10.2 million, or $0.34 per diluted share, on net sales of $106.7 million and operating income of $2.1 million. During the second quarter of 2009, RTI reported net income of $0.1 million, or $0.01 per diluted share, on net sales of $104.4 million and operating loss of $1.6 million.
Chairman and CEO Brian K Hutchison and Executive Vice President/CFO Robert P Jordheim bought shares of RTIX stock.
Oak Ridge Financial Services Inc. (BKOR, Financial): Sr. VP and CFO Thomas W Wayne Bought 5,000 Shares
Sr. VP and CFO of Oak Ridge Financial Services Inc. (BKOR) Thomas W Wayne bought 5,000 shares on 09/10/2010 at an average price of $4.75. Bank of Oak Ridge offers a complete line of banking and investment services, including savings and checking accounts, mortgage and business loans, extended weekday and Saturday branch banking hours, same-day deposits, cash management services, business and personal internet banking with balance alerts and reminders, internet bill payment, and accounts designed specifically for seniors, small businesses and civic organizations. Oak Ridge Financial Services Inc. has a market cap of $8.3 million; its shares were traded at around $4.65 with a P/E ratio of 29.1 and P/S ratio of 0.4.
Barnes Group Inc. reported financial results for the second quarter 2010. The Company reported net income of $14.8 million, or $0.26 per diluted share, compared to $10.4 million, or $0.19 per diluted share in the second quarter of 2009. Barnes Group's second quarter 2010 sales totaled $281.9 million, an increase of 10.5 percent from $255.2 million in the second quarter of 2009.
Sr. VP and CFO Thomas W Wayne and Director Douglas G Boike bought shares of BKOR stock.
PokerTek Inc. (PTEK, Financial): CEO & CFO Mark Daniel Roberson Bought 2,000 Shares
CEO & CFO of PokerTek Inc. (PTEK) Mark Daniel Roberson bought 2,000 shares on 09/02/2010 at an average price of $0.63. PokerTek, Inc. was formed to develop and market the PokerPro system, an electronic poker table that provides a fully-automated poker room environment, to tribal casinos, commercial casinos, and card clubs. Pokertek Inc. has a market cap of $8.3 million; its shares were traded at around $0.555 with and P/S ratio of 1.3.
Petrohawk Energy Corporationannounced its second quarter 2010 financial and operating results. Revenues for the quarter were $354 million before taking into account the effect of hedges. Hedging played an important role in improving realized pricing during the quarter, which brought revenues to $424 million, approximately 30% higher compared to the second quarter 2009.
CEO & CFO Mark Daniel Roberson, Director Lyle Berman, and President, 10% Owner James T Crawford Iii bought shares of PTEK stock.
CELLDEX THERAPEUTICS, INC (CLDX, Financial): Sr. VP & CFO Avery W Catlin Bought 2,000 Shares
Sr. VP & CFO of CELLDEX THERAPEUTICS, INC (CLDX) Avery W Catlin bought 2,000 shares on 09/08/2010 at an average price of $3.51. CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex Therapeutics, Inc has a market cap of $111.2 million; its shares were traded at around $3.49 with and P/S ratio of 7.3.
Celldex Therapeutics, Inc. reported financial results for the second quarter ended June 30, 2010. Celldex reported a net loss of $9.5 million, or $0.30 per share, for the second quarter of 2010 compared to a net loss of $8.7 million, or $0.55 per share, for the second quarter of 2009. At June 30, 2010, Celldex reported cash, cash equivalents and marketable securities of $65.8 million, a decrease of $9.5 million from March 30, 2010.
CLDX is in the portfolios of Paul Tudor Jones of The Tudor Group.
Sr. VP & CFO Avery W Catlin and Director Harry Jr Penner bought shares of CLDX stock.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.
GenMark Diagnostics Inc. (GNMK, Financial): CFO, Treasurer & Secretary Steven J Kemper Bought 5,000 Shares
CFO, Treasurer & Secretary of GenMark Diagnostics Inc. (GNMK) Steven J Kemper bought 5,000 shares on 09/08/2010 at an average price of $4.12. GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. Genmark Diagnostics Inc. has a market cap of $45.8 million; its shares were traded at around $3.91 .
GenMark Diagnostics, Inc. reported revenues of $651,000 for the quarter ending June 30, 2010, a 162% increase over second quarter 2009. Net loss for the second quarter was $5.1 million, or $0.60 per share, compared to a net loss of $4.3 million and $1.08 per share for the same period last year.
CFO, Treasurer & Secretary Steven J Kemper bought shares of GNMK stock.
Regeneration Technologies Inc. (RTIX, Financial): Executive Vice President/CFO Robert P Jordheim Bought 5,000 Shares
Executive Vice President/CFO of Regeneration Technologies Inc. (RTIX) Robert P Jordheim bought 5,000 shares on 09/09/2010 at an average price of $2.15. RTI BIOLOGICS, Inc. prepares human donated tissue and bovine tissue for transplantation with a commitment to advancing science, safety and innovation. Regeneration Technologies Inc. has a market cap of $123.2 million; its shares were traded at around $2.25 with a P/E ratio of 25 and P/S ratio of 0.7.
RTI International Metals, Inc. released results recently for the second quarter of 2010. During the second quarter, RTI reported net income of $10.2 million, or $0.34 per diluted share, on net sales of $106.7 million and operating income of $2.1 million. During the second quarter of 2009, RTI reported net income of $0.1 million, or $0.01 per diluted share, on net sales of $104.4 million and operating loss of $1.6 million.
Chairman and CEO Brian K Hutchison and Executive Vice President/CFO Robert P Jordheim bought shares of RTIX stock.
Oak Ridge Financial Services Inc. (BKOR, Financial): Sr. VP and CFO Thomas W Wayne Bought 5,000 Shares
Sr. VP and CFO of Oak Ridge Financial Services Inc. (BKOR) Thomas W Wayne bought 5,000 shares on 09/10/2010 at an average price of $4.75. Bank of Oak Ridge offers a complete line of banking and investment services, including savings and checking accounts, mortgage and business loans, extended weekday and Saturday branch banking hours, same-day deposits, cash management services, business and personal internet banking with balance alerts and reminders, internet bill payment, and accounts designed specifically for seniors, small businesses and civic organizations. Oak Ridge Financial Services Inc. has a market cap of $8.3 million; its shares were traded at around $4.65 with a P/E ratio of 29.1 and P/S ratio of 0.4.
Barnes Group Inc. reported financial results for the second quarter 2010. The Company reported net income of $14.8 million, or $0.26 per diluted share, compared to $10.4 million, or $0.19 per diluted share in the second quarter of 2009. Barnes Group's second quarter 2010 sales totaled $281.9 million, an increase of 10.5 percent from $255.2 million in the second quarter of 2009.
Sr. VP and CFO Thomas W Wayne and Director Douglas G Boike bought shares of BKOR stock.
PokerTek Inc. (PTEK, Financial): CEO & CFO Mark Daniel Roberson Bought 2,000 Shares
CEO & CFO of PokerTek Inc. (PTEK) Mark Daniel Roberson bought 2,000 shares on 09/02/2010 at an average price of $0.63. PokerTek, Inc. was formed to develop and market the PokerPro system, an electronic poker table that provides a fully-automated poker room environment, to tribal casinos, commercial casinos, and card clubs. Pokertek Inc. has a market cap of $8.3 million; its shares were traded at around $0.555 with and P/S ratio of 1.3.
Petrohawk Energy Corporationannounced its second quarter 2010 financial and operating results. Revenues for the quarter were $354 million before taking into account the effect of hedges. Hedging played an important role in improving realized pricing during the quarter, which brought revenues to $424 million, approximately 30% higher compared to the second quarter 2009.
CEO & CFO Mark Daniel Roberson, Director Lyle Berman, and President, 10% Owner James T Crawford Iii bought shares of PTEK stock.
CELLDEX THERAPEUTICS, INC (CLDX, Financial): Sr. VP & CFO Avery W Catlin Bought 2,000 Shares
Sr. VP & CFO of CELLDEX THERAPEUTICS, INC (CLDX) Avery W Catlin bought 2,000 shares on 09/08/2010 at an average price of $3.51. CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex Therapeutics, Inc has a market cap of $111.2 million; its shares were traded at around $3.49 with and P/S ratio of 7.3.
Celldex Therapeutics, Inc. reported financial results for the second quarter ended June 30, 2010. Celldex reported a net loss of $9.5 million, or $0.30 per share, for the second quarter of 2010 compared to a net loss of $8.7 million, or $0.55 per share, for the second quarter of 2009. At June 30, 2010, Celldex reported cash, cash equivalents and marketable securities of $65.8 million, a decrease of $9.5 million from March 30, 2010.
CLDX is in the portfolios of Paul Tudor Jones of The Tudor Group.
Sr. VP & CFO Avery W Catlin and Director Harry Jr Penner bought shares of CLDX stock.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.
